Creation of 140 new jobs as GE Healthcare opens new manufacturing line at Cork facility

Kevin O’Neill, President & CEO GE Healthcare Pharmaceutical Diagnostics, Minister for Public Expenditure and Reform Michael McGrath T.D, GE Healthcare Site Lead Eugene Barrett, Tanya O’Sullivan, QA Analyst and Michael Lohan, Head of Life Sciences IDA Ireland at the opening of the new €30.5 Million Manufacturing Line at GE Healthcare in Carrigtohill, Co. Cork 140 new jobs are being created at the site, which manufactures injectable diagnostic imaging agents (contrast media) used in Xray and Computed Tomography (CT) procedures around the world.Photo Darragh Kane
MINISTER for Public Expenditure and Reform Michael McGrath will today officially open a new €30.5 million ($30 million) manufacturing line at GE Healthcare’s Carrigtohill, Co. Cork facility.
The new line, which has created 140 jobs, manufactures injectable diagnostic imaging agents (contrast media) used in Xray and Computed Tomography (CT) procedures around the world.

Minister McGrath said: “GE Healthcare has consistently invested in manufacturing here in Cork, bringing together state-of-the-art technology, global best practices in pharmaceutical healthcare and a highly qualified workforce. I am delighted today to open the newest filling line at the Cork campus, and welcome the creation of 140 jobs at the plant.
The growing global prevalence of chronic disorders has driven significant growth in Computed Tomography (CT) procedures, leading to increased demand for iodinated contrast media, used to enhance visualization of organs, blood vessels and tissues across disease pathways.
GE Healthcare’s Pharmaceutical Diagnostics business develops and manufactures imaging agents used to support over 100 million procedures per year globally, equivalent to three patient procedures every second. It is estimated that the new manufacturing line will increase production capacity at the Cork facility by over 50 percent by 2025.

President & CEO of GE Healthcare Pharmaceutical Diagnostics, Kevin O’Neill, said, “We expect global demand for iodinated contrast media to double over the next ten years due to the growth of CT imaging procedures. As an industry leader, we understand our responsibility to help meet this growing demand from customers and patients and this new production line is part of our wider commitment to produce 30 million more patient doses of contrast media annually by 2025.”
Eugene Barrett, GE Healthcare Ireland Site Leader, who leads the 765 strong team at the Cork facility, said, “We have a great team here in Cork focused on supplying for our customers and their patients. Next year marks our 30-year anniversary of production and this new production line is central to our continued growth. We are delighted to have Minister McGrath and Kevin O’Neill on campus to celebrate this milestone.”
IDA Ireland Executive Director Mary Buckley said,
Roles currently open at GE Healthcare include operatives, project managers, engineers, quality control personnel as well as facility management.
Current jobs are open to applications here.
Cork Chamber has welcomed the €30 million investment.
“This investment and the jobs created by GE Healthcare is great news for Cork. It’s another major investment by a global leader in the life sciences sector in Cork and shows that we continue to be the investment destination of choice for the global life sciences and pharmaceutical industry,” said Cork Chamber CEO Conor Healy.

“GE have been in Cork for almost 30 years, and this €30 million investment in a new manufacturing line shows their enduring commitment for the long term, as well as the high quality of workforce and economic environment available here for leading global companies."
“We need to continue to create the conditions in the Cork region that make these investments possible and that includes investment in sustainable transport and infrastructure including accelerating investment in delivery of new suburban rail stations and cycle ways to support continued job and investment growth in this part of East Cork."
“With continuing investment flowing into this area Government needs to revisit and reverse its decision not to fund the N25 Carrigtwohill to Midleton multi-modal route as a key enabler to continued job growth and investment in East Cork.”